After thirty years of experience with early postoperative intraperitoneal 5-fluorouracil now saying goodbye-Reference-Cited by-同舟云学术

After thirty years of experience with early postoperative intraperitoneal 5-fluorouracil now saying goodbye

Published:2022-06 Issue: Volume:42 Page:101757
ISSN:0960-7404
Container-title:Surgical Oncology
language:en
Short-container-title:Surgical Oncology

Author:

Sugarbaker Paul H.^ORCID

Publisher

Elsevier BV

Subject

Oncology,Surgery

Reference43 articles.

1. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial;Quénet;Lancet Oncol.,2021

2. The many faces of intraperitoneal chemotherapy;Abdel Mageed;Surg Oncol,2021

3. HIPEC trials and the USA: a review and call to action;Pameijer;Ann. Surg Oncol.,2022

4. HIPEC for colorectal and appendiceal peritoneal metastases. Lessons learned from PRODIGE 7;Cashin;J Gastrointes. Oncol. Focused Iss. Intraperit. Chemother. for Peritoneal Metastases. HIPEC, EPIC, NIPEC, PIPAC and more,2020

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progress in the Treatment of Peritoneal Metastatic Cancer and the Application of Therapeutic Nanoagents;ACS Applied Bio Materials;2023-11-02

2. Use of early postoperative intraperitoneal 5‐fluorouracil with index cytoreduction improves survival with secondary cytoreductive surgery;Journal of Surgical Oncology;2023-10-12

3. ZnO as a promising nanocarrier for efficient delivery of 5-fluorouracil anticancer drug;Journal of the Iranian Chemical Society;2023-09-23

4. Determinants of Outcome with Reoperative Surgery for Pseudomyxoma Peritonei in 186 Patients;Annals of Surgery Open;2023-09

5. Investigation of the effectiveness of hyperthermic intraperitoneal chemotherapy in experimental colorectal peritoneal metastasis model;Pleura and Peritoneum;2023-05-10